|
41
|
0011AA
|
CHLORPHENIRAMINE 4MG TAB (GPC/ATB)
|
1000'S
|
A
|
0.0169
|
4MG
|
84
|
|
|
|
|
|
0
|
|
41
|
0011M
|
HISTAL 4MG TAB (CAR/COL) CHLORPHENIRAMINE
|
1000'S
|
A
|
0.0334
|
4MG
|
84
|
|
|
|
|
|
0
|
|
40
|
0011M
|
HISTAL 4MG TAB (CAR/COL) CHLORPHENIRAMINE
|
1000'S
|
A
|
0.03
|
4MG
|
84
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
0012AB
|
ALLEGRA 120MG TAB (SFA/COL) FEXOFENADINE
|
10'S
|
C
|
0.95
|
120MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
0012AB
|
ALLEGRA 120MG TAB (SFA/COL) FEXOFENADIN (C)
|
10'S
|
C
|
1.631
|
120MG
|
|
2022-12-10
|
2024-03-31
|
No
|
No
|
Price Change
|
0
|
|
41
|
0012AN
|
MEQUILAN 5MG TAB (CAR/COL) MEQUITAZINE
|
112'S
|
A
|
0.3786
|
5MG
|
28
|
|
|
|
|
|
0
|
|
40
|
0012AN
|
MEQUILAN 5MG TAB (CAR/COL) MEQUITAZINE
|
112'S
|
A
|
0.38
|
5MG
|
28
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
0012AQ
|
ALLEGRA 180MG TAB (SFA/COL) FEXOFENADINE
|
10'S
|
C
|
1.02
|
180MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
0012AQ
|
ALLEGRA 180MG TAB (SFA/COL) FEXOFENADIN (C)
|
10'S
|
C
|
2.419
|
180MG
|
|
2022-12-10
|
2024-03-31
|
No
|
No
|
Price Change
|
0
|
|
40
|
0012BA
|
APO-CETIRIZINE 10MG TAB (APO/COL)
|
100'S
|
A
|
0.08
|
10MG
|
14
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
0012BB
|
APO-LORATADINE 10MG TAB (APO/COL)
|
100'S
|
A
|
0.09
|
10MG
|
14
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
41
|
0012BK
|
REMIDINE 10MG TAB (REM/SBI) LORATADINE
|
2x10
|
A
|
0.0843
|
10MG
|
14
|
|
|
|
|
|
0
|
|
40
|
0012BK
|
REMIDINE 10MG TAB (REM/SBI) LORATADINE
|
2x10
|
A
|
0.09
|
10MG
|
14
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
41
|
0012EA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
|
0012EA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
|
0012EA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
|
0012EA
|
DESLORA-DENK 5MG TAB (EDK/COL) DESLORATADINE
|
10'S
|
C
|
0.2066
|
5MG
|
0
|
|
|
|
|
|
0
|
|
40
|
0012EA
|
DESLORA-DENK 5MG TAB (EDK/COL) DESLORATADINE
|
10'S
|
C
|
0.31
|
5MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
0012EJ
|
LORATADINE 10MG TAB (KWA/ATB)
|
10X10
|
A
|
0.05
|
10MG
|
14
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
41
|
0012EP
|
|
|
|
|
|
|
|
|
|
|
|
|